ÂÜÀòÂÒÂ×

Victoria Lipatova is an experienced investor currently engaged with Aegis BioDefense Inc. since 2020 and as a private investor since July 2018, focusing on emerging trillion-dollar industries anticipated to transform various sectors. Additional investments include Algorand, Volumetric, SpaceX, Relativity Space, Oisin Biotechnologies, and Arweave. Victoria Lipatova previously held positions as a leading specialist at Rosatom Global, responsible for market analytics, and as a consultant at KPMG, where market analysis and project presentation preparation were key responsibilities. Education includes a bachelor's degree in Business Informatics from the Higher School of Economics, completed in 2015.